Li Zhu
Director/Board Member chez GENSCRIPT BIOTECH CORPORATION
Fortune : 2 M $ au 31/03/2024
Profil
Li Zhu is the founder of Genetastix Corp.
He is currently the Executive Director & Chief Strategy Officer at Genscript Biotech Corp., the Director at Legend Biotech Corp., and the Vice President-Marketing & Strategy at Nanjingjinsirui Science & Technology Biology Corp.
Dr. Zhu's former positions include being the Director-Molecular Biology at Takara Bio USA, Inc. from 1990 to 2000, the Principal at Genentech, Inc. in 2006, the Principal at HUYA Bioscience International LLC in 2010, the Principal at Cathay Industrial Biotech Ltd.
in 2008, the Vice President-Research at Cathay Biotech, Inc. from 2006 to 2008, and the Vice President at Huya Biomedical Technology Shanghai Co., Ltd.
Dr. Zhu obtained a doctorate degree from Stanford University in 1989 and an undergraduate degree from East China Normal University in 1982.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/03/2024 | 1 232 771 ( 0,06% ) | 2 M $ | 31/03/2024 |
Postes actifs de Li Zhu
| Sociétés | Poste | Début |
|---|---|---|
| GENSCRIPT BIOTECH CORPORATION | Director/Board Member | 22/11/2020 |
| LEGEND BIOTECH CORPORATION | Director/Board Member | 23/11/2020 |
Nanjingjinsirui Science & Technology Biology Corp.
 Nanjingjinsirui Science & Technology Biology Corp. BiotechnologyHealth Technology Nanjing Genscript Co., Ltd. provides biological and pharmaceutical research services. It offers gene, peptide, protein production and purification, and antibody outsourcing services. The company was founded in 2004 and is headquartered in Nanjing, China. | Sales & Marketing | - |
Anciens postes connus de Li Zhu
| Sociétés | Poste | Fin |
|---|---|---|
HUYA Bioscience International LLC
 HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2010 |
Cathay Industrial Biotech Ltd.
 Cathay Industrial Biotech Ltd. Chemicals: SpecialtyProcess Industries Cathay Industrial Biotech Ltd. develops, manufactures, and commercializes chemicals, fuels, and polymers. It offers dibasic acids, pentamethylene diamine, terryl for textiles, engineering polymers, toll production, and technology development. The company was founded by XiuCai Liu and QiXian Zhang in 1997 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01/01/2008 |
| CATHAY BIOTECH INC. | Chief Tech/Sci/R&D Officer | 01/01/2008 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2006 |
Takara Bio USA, Inc.
 Takara Bio USA, Inc. Medical/Nursing ServicesHealth Services Takara Bio USA, Inc. helps to accelerate the discovery process by providing pioneering tools that enable researchers to ask new questions and investigate ever more complex systems than was previously possible. With more than 5,000 literature citations, its innovative products and services continue to facilitate advancement in areas such as genomics, cancer research, apoptosis, cytogenetics, developmental genetics, cellular physiology, pharmocogenetics, and neurobiology. | Corporate Officer/Principal | 01/01/2000 |
Formation de Li Zhu
| Stanford University | Doctorate Degree |
| East China Normal University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| GENSCRIPT BIOTECH CORPORATION | Health Technology |
| LEGEND BIOTECH CORPORATION | Health Technology |
| CATHAY BIOTECH INC. | Process Industries |
| Entreprise privées | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Takara Bio USA, Inc.
Takara Bio USA, Inc. Medical/Nursing ServicesHealth Services Takara Bio USA, Inc. helps to accelerate the discovery process by providing pioneering tools that enable researchers to ask new questions and investigate ever more complex systems than was previously possible. With more than 5,000 literature citations, its innovative products and services continue to facilitate advancement in areas such as genomics, cancer research, apoptosis, cytogenetics, developmental genetics, cellular physiology, pharmocogenetics, and neurobiology. | Health Services |
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Health Technology |
Cathay Industrial Biotech Ltd.
Cathay Industrial Biotech Ltd. Chemicals: SpecialtyProcess Industries Cathay Industrial Biotech Ltd. develops, manufactures, and commercializes chemicals, fuels, and polymers. It offers dibasic acids, pentamethylene diamine, terryl for textiles, engineering polymers, toll production, and technology development. The company was founded by XiuCai Liu and QiXian Zhang in 1997 and is headquartered in Shanghai, China. | Process Industries |
Nanjingjinsirui Science & Technology Biology Corp.
Nanjingjinsirui Science & Technology Biology Corp. BiotechnologyHealth Technology Nanjing Genscript Co., Ltd. provides biological and pharmaceutical research services. It offers gene, peptide, protein production and purification, and antibody outsourcing services. The company was founded in 2004 and is headquartered in Nanjing, China. | Health Technology |
| Genetastix Corp. | |
| Huya Biomedical Technology Shanghai Co., Ltd. |
